Tests and Expenditures in the Initial Evaluation of Peripheral Neuropathy
Open Access
- 23 January 2012
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 172 (2) , 127-132
Abstract
Peripheral neuropathy is a common and debilitating condition with a prevalence of 2% to 7% in the general population.1,2 The prevalence increases significantly in older adults, with a prevalence of approximately 15% in those older than 40 years.3 Distal symmetric polyneuropathy (DSP) is the most common subtype of neuropathy.4 Previous research suggests that a focused and directed evaluation is the optimal diagnostic approach in this patient population.5 The best evidence for diagnostic testing in DSP was recently summarized in a systematic review by the American Academy of Neurology (AAN).4 Fasting glucose levels, vitamin B12 levels, serum protein electrophoresis (SPEP), and 2-hour oral glucose tolerance tests (GTTs) were supported by the literature based on the yield of these tests and the potential for subsequent interventions.4 A fasting glucose level is the most frequently used test to diagnose diabetes, which is the most common cause of DSP.6 Vitamin B12 deficiency causes a potentially treatable neuropathy with different characteristics than those in idiopathic neuropathy.7 The use of GTTs and SPEP is supported by evidence8-10 that patients with neuropathy have a substantially increased prevalence of these abnormalities compared with control groups. Evidence to support other diagnostic tests in the evaluation of DSP is lacking.Keywords
This publication has 18 references indexed in Scilit:
- Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review)Neurology, 2009
- Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population‐based studyMuscle & Nerve, 2007
- Specificity and Sensitivity of Claims‐Based Algorithms for Identifying Members of Medicare+Choice Health Plans That Have Chronic Medical ConditionsHealth Services Research, 2004
- A controlled investigation of the cause of chronic idiopathic axonal polyneuropathyBrain, 2004
- Malformation of the radial glial scaffold in the dentate gyrus of reeler mice, scrambler mice, and ApoER2/VLDLR‐deficient miceJournal of Comparative Neurology, 2003
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Prevalence of diabetic neuropathy with somatic symptomsNeurology, 1993
- Prevalence of peripheral neuropathy in the Parsi community of BombayNeurology, 1991
- Chronic polyneuropathy of undetermined cause.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Prevalence of monoclonal protein in peripheral neuropathyNeurology, 1981